- Should studies of maintenance therapy be maintained in women with ovarian cancer?
-
Bookman MA
- KMID: 2288539
- J Gynecol Oncol.
- 2013 Apr;24(2):105-107.
- doi: 10.3802/jgo.2013.24.2.105
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- LNG-IUS treatment of non-atypical endometrial hyperplasia: Can Pipelle endometrial sampling be an accurate method of follow-up evaluation?
-
Kim MK, Seong SJ
- KMID: 2288538
- J Gynecol Oncol.
- 2013 Apr;24(2):103-104.
- doi: 10.3802/jgo.2013.24.2.103
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study
-
Karabuk E, Kose MF, Hizli D, Taskin S, Karadag B, Turan T, Boran N, Ozfuttu A, Ortac UF
- KMID: 2288548
- J Gynecol Oncol.
- 2013 Apr;24(2):160-166.
- doi: 10.3802/jgo.2013.24.2.160
OBJECTIVE: The aim of this study was to compare clinicopathologic characteristics, surgery outcomes and survival outcomes of patients with stage III and IV mucinous epithelial ovarian cancer (mEOC) and serous... -
- CITED
-
- Close
- SHARE
-
- Close
- Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition
-
Lee JK, Hong JH, Kang S, Kim DY, Kim BG, Kim SH, Kim YM, Kim JW, Kim JH, Kim TJ, Kim HJ, Kim HS, Ryu HS, Song JY, Ahn HS, Yoo CW, Yoon HK, Lee KH, Lee A, Lee Y, Lee IH, Lee JW, Lee TS, Lim MC, Chang SJ, Chung HH, Ju W, Joo HJ, Hur SY, Hong SR, Nam JH
- KMID: 2288551
- J Gynecol Oncol.
- 2013 Apr;24(2):186-203.
- doi: 10.3802/jgo.2013.24.2.186
The consensus guideline development committee of Korean Society of Gynecologic Oncology was reconvened in March 2012. The committee consisted of 36 experts representing 12 university hospitals and professional organizations. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques?
-
Kulac I, Usubutun A
- KMID: 2288541
- J Gynecol Oncol.
- 2013 Apr;24(2):114-119.
- doi: 10.3802/jgo.2013.24.2.114
OBJECTIVE: Extrauterine involvement of endometrial carcinoma has a significant effect on the patients' prognosis and treatment decision. In classical method, macroscopic section is taken from the fallopian tube sparing the... -
- CITED
-
- Close
- SHARE
-
- Close
- Maintenance of ovarian function in end-of-life cervical cancer patient following primary surgico-radiotherapy and ovarian transposition
-
Sicam RV, Huang KG, Chang YC, Lee CL
- KMID: 2288552
- J Gynecol Oncol.
- 2013 Apr;24(2):204-207.
- doi: 10.3802/jgo.2013.24.2.204
A 35-year-old woman underwent laparoscopic radical hysterectomy, pelvic lymphadenectomy and ovarian transposition for stage IB2 cervical adenocarcinoma. She received adjuvant concurrent chemoradiation for poor pathologic risk factors but had tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Reproductive factors for ovarian cancer in southern Chinese women
-
Pasalich M, Su D, Binns CW, Lee AH
- KMID: 2288544
- J Gynecol Oncol.
- 2013 Apr;24(2):135-140.
- doi: 10.3802/jgo.2013.24.2.135
OBJECTIVE: To investigate the association between reproductive factors and the risk of ovarian cancer among southern Chinese women. METHODS: A hospital-based case-control study was undertaken in Guangzhou, Guangdong Province, between 2006... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapy
-
Chang JS, Koom WS, Kim SW, Kim S, Kim YB, Kim YT, Kim GE
- KMID: 2288546
- J Gynecol Oncol.
- 2013 Apr;24(2):146-153.
- doi: 10.3802/jgo.2013.24.2.146
OBJECTIVE: To analyze patterns of abdominopelvic failures and to define subgroups for the use of adjuvant radiotherapy in the International Federation of Gynecology and Obstetrics (FIGO) stage III epithelial ovarian... -
- CITED
-
- Close
- SHARE
-
- Close
- LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial
-
Abu Hashim H, Zayed A, Ghayaty E, El Rakhawy M
- KMID: 2288543
- J Gynecol Oncol.
- 2013 Apr;24(2):128-134.
- doi: 10.3802/jgo.2013.24.2.128
OBJECTIVE: To compare the efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS) and oral norethisterone acetate (NET) for treatment of non-atypical endometrial hyperplasia in perimenopausal women. METHODS: One hundred and twenty perimenopausal... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system
-
Kim HJ, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG
- KMID: 2288542
- J Gynecol Oncol.
- 2013 Apr;24(2):120-127.
- doi: 10.3802/jgo.2013.24.2.120
OBJECTIVE: This study was designed to compare survival outcomes of patients with uterine papillary serous carcinoma (UPSC) or clear cell carcinoma (CC) to those of patients with grade 3 endometrioid... -
- CITED
-
- Close
- SHARE
-
- Close
- CA-125 cut-off value as a predictor for complete interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer
-
Furukawa N, Sasaki Y, Shigemitsu A, Akasaka J, Kanayama S, Kawaguchi , Kobayashi
- KMID: 2288545
- J Gynecol Oncol.
- 2013 Apr;24(2):141-145.
- doi: 10.3802/jgo.2013.24.2.141
OBJECTIVE: In the present study, we evaluated changes in CA-125 cut-off values predictive of complete interval debulking surgery (IDS) after neoadjuvant chemotherapy (NAC) using receiver operating characteristic (ROC) analysis. METHODS: This... -
- CITED
-
- Close
- SHARE
-
- Close
- A feasibility study on maintenance of docetaxel after paclitaxel-carboplatin chemotherapy in patients with advanced ovarian cancer
-
Isonishi S, Suzuki M, Nagano H, Takagi K, Shimauchi , Kawabata M, Ochiai K
- KMID: 2288547
- J Gynecol Oncol.
- 2013 Apr;24(2):154-159.
- doi: 10.3802/jgo.2013.24.2.154
OBJECTIVE: To test the concept of taxane sequencing, this feasibility trial evaluated maintenance of docetaxel after paclitaxel and carboplatin combination chemotherapy in patients with stage IC-IV ovarian cancer. METHODS: All patients... -
- CITED
-
- Close
- SHARE
-
- Close
- The mechanism of mesna in protection from cisplatin-induced ovarian damage in female rats
-
Li X, Yang S, Lv X, Sun H, Weng J, Liang Y, Zhou D
- KMID: 2288550
- J Gynecol Oncol.
- 2013 Apr;24(2):177-185.
- doi: 10.3802/jgo.2013.24.2.177
OBJECTIVE: Cisplatin is a widely used chemotherapeutic agent in the treatment of cancers in clinic; but it often induces adverse effects on ovarian functions such as reduced fertility and premature... -
- CITED
-
- Close
- SHARE
-
- Close
- Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
-
Ushijima K, Fujiyoshi , Kawano K, Tsuda N, Nishio S, Eto H, Kamura T
- KMID: 2288540
- J Gynecol Oncol.
- 2013 Apr;24(2):108-113.
- doi: 10.3802/jgo.2013.24.2.108
OBJECTIVE: To evaluate the clinical efficacy of concurrent chemoradiotherapy (CCRT) using daily low-dose cisplatin for cervical cancer. METHODS: Fifty-one patients with locally advanced cervical cancer (FIGO stage IB2, bulky IIA, IIB-IVA)... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival of women with ovarian carcinomas and borderline tumors is not affected by estrogen and progesterone receptor status
-
Sallum LF, Sarian LO, Lucci De Angelo Andrade L, Vassallo J, Soares FA, Pinto GA, Ferreira P, Derchain S
- KMID: 2288549
- J Gynecol Oncol.
- 2013 Apr;24(2):167-176.
- doi: 10.3802/jgo.2013.24.2.167
OBJECTIVE: To examine the patterns of estrogen receptor (ER) and progesterone receptor (PR) expression in borderline ovarian tumors (BOTs) and ovarian carcinomas. We also assessed the disease-free survival (DFS) and... -
- CITED
-
- Close
- SHARE
-
- Close
